Ray Dalio Guardant Health, Inc. Transaction History

Bridgewater Associates, LP

$23.3 Billion
Q2 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 3,870 shares of GH stock, worth $271,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,870

Previous 5,070 23.67%

Holding current value

$271,674

Previous $215,000 6.51%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$37.05 - $52.04 $44,460 - $62,448	-1,200 Reduced 23.67%	3,870 $201,000
Q1 2025 May 14, 2025	SELL	$31.77 - $49.94 $237,448 - $373,251	-7,474 Reduced 59.58%	5,070 $215,000
Q4 2024 Feb 13, 2025	SELL	$20.2 - $38.11 $113,039 - $213,263	-5,596 Reduced 30.85%	12,544 $383,000
Q3 2024 Nov 13, 2024	SELL	$22.3 - $36.29 $45,960 - $74,793	-2,061 Reduced 10.2%	18,140 $415,000
Q2 2024 Aug 14, 2024	SELL	$16.07 - $31.84 $1.41 Million - $2.79 Million	-87,615 Reduced 81.26%	20,201 $583,000
Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $1.25 Million - $1.96 Million	72,699 Added 207.02%	107,816 $2.22 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $41,153 - $56,256	-1,907 Reduced 5.15%	35,117 $949,000
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $43,215 - $66,949	1,675 Added 4.74%	37,024 $1.1 Million
Q2 2023 Aug 11, 2023	SELL	$20.94 - $38.01 $1,800 - $3,268	-86 Reduced 0.24%	35,349 $1.27 Million
Q1 2023 May 12, 2023	SELL	$22.92 - $33.76 $2.13 Million - $3.14 Million	-93,111 Reduced 72.43%	35,435 $830,000
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $786,528 - $1.85 Million	-30,917 Reduced 19.39%	128,546 $3.5 Million
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $131,634 - $183,915	-3,015 Reduced 1.86%	159,463 $8.58 Million
Q2 2022 Aug 11, 2022	BUY	$28.82 - $77.35 $560,174 - $1.5 Million	19,437 Added 13.59%	162,478 $6.55 Million
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $1.83 Million - $3.81 Million	37,888 Added 36.03%	143,041 $9.48 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $106,008 - $143,913	1,195 Added 1.15%	105,153 $10.5 Million
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $474,293 - $634,680	-4,802 Reduced 4.42%	103,958 $13 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $4.62 Million - $6.98 Million	42,114 Added 63.19%	108,760 $13.5 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $1.31 Million - $1.84 Million	10,279 Added 18.24%	66,646 $10.2 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $3.25 Million - $4.42 Million	32,496 Added 136.13%	56,367 $7.27 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $1.92 Million - $2.67 Million	23,871 New	23,871 $2.67 Million

Others Institutions Holding GH

# of Institutions

419

Shares Held

126M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $7.18B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account